You can buy or sell Orgenesis and other stocks, options, and ETFs commission-free!
Orgenesis Inc. Common Stock, also called Orgenesis, is a biotechnology company, which engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. It operates through the Contract Development and Manufacturing Organization (CDMO) and Point-Of-Care Cell Therapy (POC) segments. The CDMO segment through MaSTherCell, comprises of services from cell therapy development through cell therapy manufacturing for and companies that provide end-to-end solution. The POC segment provides multitude of cell therapies including, but not limited to, cell-based immunotherapies, therapeutics for metabolic diseases, neurodegenerative diseases and tissue regeneration. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD. The listed name for ORGS is Orgenesis Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 9, Pre-Market